We are developing a pipeline of unique small-molecule product candidates, each with several “shots on goal” in both orphan and major cancer markets. Our goal is address shortcomings of approved therapies and improve the lives of cancer patients whose tumors harbor mutations known to be targeted by our product candidates.
Company Profile
Contact Information
Investor Relations Counsel
Amato and Partners LLC
New York / San Diego
T: (212) 430-0360
gerald@amatoandpartners.com
amatoandpartners.com
Company Contact
Edison Oncology Holding Corp
3475 Edison Way
Suite R
Menlo Park, CA 94025